首页 > 最新文献

JAMA Health Forum最新文献

英文 中文
Medicaid Continuous Coverage Requirement and Postpartum Hospitalization. 医疗补助持续覆盖要求和产后住院。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6872
Giacomo Meille, Maria W Steenland, Erica L Eliason
<p><strong>Importance: </strong>In 2020, all US states adopted the Families First Coronavirus Response Act Medicaid continuous coverage requirement (CCR), which prevented disenrollment from Medicaid. This policy effectively extended pregnancy-related Medicaid eligibility beyond the previous end date of 60 days post partum.</p><p><strong>Objective: </strong>To determine whether the CCR was associated with a change in postpartum hospitalization rates for mothers covered by Medicaid during their delivery.</p><p><strong>Design, setting, and participants: </strong>This cohort study was conducted from December 2023 to March 2025 at all nonfederal acute care hospitals in 20 states using data from the Healthcare Cost and Utilization Project's State Inpatient Databases from 2018 through 2021. Participants included mothers aged 18 to 55 years who had Medicaid-paid deliveries (based on the primary expected payer) from January 2018 to June 2021; they were followed up for 180 days post partum.</p><p><strong>Exposures: </strong>State-level postpartum uninsured rate among mothers with Medicaid-paid deliveries that occurred from 2018 to 2019 (before the CCR was implemented in 2020). Residency in states with an uninsured rate above the median was considered to be high exposure (ie, a greater share of the state population had the potential to benefit from the CCR) and residency in states with a preperiod uninsured rate below the median was considered low exposure.</p><p><strong>Main outcomes and measures: </strong>Probability of a mother being hospitalized 1 to 60 days post partum (covered under previous Medicaid eligibility rules) and 61 to 180 days post partum (newly covered under the CCR).</p><p><strong>Results: </strong>A total of 2 024 214 mothers (mean age, 27.5 [95% CI, 27.5-27.5] years) with Medicaid-paid deliveries were identified. The sample included 550 881 deliveries by Hispanic mothers (27.2%), 490 586 deliveries by non-Hispanic Black mothers (24.2%), 744 945 deliveries by non-Hispanic White mothers (36.8%), 200 639 deliveries by mothers of other races and ethnicities (9.9%), and 37 163 deliveries by mothers with missing race and ethnicity data (1.8%). Among the full sample, 931 452 mothers (mean age, 27.1 [95% CI, 27.71-27.2] years) resided in high-exposure states and 1 092 762 mothers (mean age, 27.8 [95% CI, 27.8-27.8] years) resided in low-exposure states. In adjusted difference-in-differences models, the rate of hospitalization per 1000 Medicaid-paid deliveries at 61 to 180 days post partum decreased (adjusted β coefficient, -1.4; 95% CI, -2.5 to -0.3) in high-exposure states compared with low-exposure states, a 10.9% decrease relative to the preperiod mean (12.9; 95% CI, 12.6 to 13.2) in high-exposure states. The analogous estimate for the hospitalization rates 1 to 60 days post partum was not statistically significant (-0.7 [95% CI, -2.0 to 0.5] per 1000 Medicaid-paid deliveries).</p><p><strong>Conclusions and relevance: </strong>Findings of th
重要性:2020年,美国所有州都通过了《家庭第一冠状病毒应对法案》医疗补助持续覆盖要求(CCR),从而防止了从医疗补助计划中除名。这项政策有效地延长了与怀孕有关的医疗补助资格,超过了之前的产后60天结束日期。目的:确定CCR是否与接受医疗补助的母亲分娩期间产后住院率的变化有关。设计、环境和参与者:本队列研究于2023年12月至2025年3月在20个州的所有非联邦急性护理医院进行,使用2018年至2021年医疗保健成本和利用项目的州住院患者数据库中的数据。参与者包括18至55岁的母亲,她们在2018年1月至2021年6月期间接受了医疗补助支付的分娩(基于主要预期付款人);随访时间为产后180天。暴露:2018年至2019年(CCR于2020年实施之前)使用医疗补助分娩的母亲的国家级产后未参保率。居住在未投保率高于中位数的州被认为是高暴露(即,更大比例的州人口有可能受益于CCR),居住在未投保率低于中位数的州被认为是低暴露。主要结果和衡量标准:母亲产后1至60天住院的概率(在以前的医疗补助资格规则下包括)和产后61至180天住院的概率(在新的CCR下包括)。结果:共有2 024 214名母亲(平均年龄27.5岁[95% CI, 27.5-27.5]岁)接受医疗补助分娩。样本包括西班牙裔母亲分娩550881次(27.2%),非西班牙裔黑人母亲分娩490586次(24.2%),非西班牙裔白人母亲分娩744945次(36.8%),其他种族和族裔母亲分娩200639次(9.9%),以及37 163次由缺少种族和族裔数据的母亲分娩(1.8%)。在整个样本中,931 452名母亲(平均年龄27.1 [95% CI, 27.71-27.2]岁)居住在高暴露状态,1 092 762名母亲(平均年龄27.8 [95% CI, 27.8-27.8]岁)居住在低暴露状态。在调整后的差异中差异模型中,与低暴露状态相比,高暴露状态下每1000例医疗补助支付分娩的住院率(调整后的β系数,-1.4;95% CI, -2.5至-0.3)在产后61至180天下降,相对于高暴露状态下的前期平均值(12.9;95% CI, 12.6至13.2)下降10.9%。产后1至60天住院率的类似估计没有统计学意义(每1000例医疗补助支付分娩-0.7 [95% CI, -2.0至0.5])。结论和相关性:本研究的发现表明,居住在高暴露州与产后61至180天(新扩大的医疗补助覆盖范围)的母亲住院率减少有关。扩大医疗补助覆盖范围可能有助于改善产后健康,减少低收入母亲的不良事件。
{"title":"Medicaid Continuous Coverage Requirement and Postpartum Hospitalization.","authors":"Giacomo Meille, Maria W Steenland, Erica L Eliason","doi":"10.1001/jamahealthforum.2025.6872","DOIUrl":"10.1001/jamahealthforum.2025.6872","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;In 2020, all US states adopted the Families First Coronavirus Response Act Medicaid continuous coverage requirement (CCR), which prevented disenrollment from Medicaid. This policy effectively extended pregnancy-related Medicaid eligibility beyond the previous end date of 60 days post partum.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To determine whether the CCR was associated with a change in postpartum hospitalization rates for mothers covered by Medicaid during their delivery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This cohort study was conducted from December 2023 to March 2025 at all nonfederal acute care hospitals in 20 states using data from the Healthcare Cost and Utilization Project's State Inpatient Databases from 2018 through 2021. Participants included mothers aged 18 to 55 years who had Medicaid-paid deliveries (based on the primary expected payer) from January 2018 to June 2021; they were followed up for 180 days post partum.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposures: &lt;/strong&gt;State-level postpartum uninsured rate among mothers with Medicaid-paid deliveries that occurred from 2018 to 2019 (before the CCR was implemented in 2020). Residency in states with an uninsured rate above the median was considered to be high exposure (ie, a greater share of the state population had the potential to benefit from the CCR) and residency in states with a preperiod uninsured rate below the median was considered low exposure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;Probability of a mother being hospitalized 1 to 60 days post partum (covered under previous Medicaid eligibility rules) and 61 to 180 days post partum (newly covered under the CCR).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 2 024 214 mothers (mean age, 27.5 [95% CI, 27.5-27.5] years) with Medicaid-paid deliveries were identified. The sample included 550 881 deliveries by Hispanic mothers (27.2%), 490 586 deliveries by non-Hispanic Black mothers (24.2%), 744 945 deliveries by non-Hispanic White mothers (36.8%), 200 639 deliveries by mothers of other races and ethnicities (9.9%), and 37 163 deliveries by mothers with missing race and ethnicity data (1.8%). Among the full sample, 931 452 mothers (mean age, 27.1 [95% CI, 27.71-27.2] years) resided in high-exposure states and 1 092 762 mothers (mean age, 27.8 [95% CI, 27.8-27.8] years) resided in low-exposure states. In adjusted difference-in-differences models, the rate of hospitalization per 1000 Medicaid-paid deliveries at 61 to 180 days post partum decreased (adjusted β coefficient, -1.4; 95% CI, -2.5 to -0.3) in high-exposure states compared with low-exposure states, a 10.9% decrease relative to the preperiod mean (12.9; 95% CI, 12.6 to 13.2) in high-exposure states. The analogous estimate for the hospitalization rates 1 to 60 days post partum was not statistically significant (-0.7 [95% CI, -2.0 to 0.5] per 1000 Medicaid-paid deliveries).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;Findings of th","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256872"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12949437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147311507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dental Coverage Through Medicaid Managed Care vs Fee-for-Service. 通过医疗补助管理医疗的牙科保险vs按服务收费。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6958
Hawazin W Elani, Ningsheng Zhao, Jacob Wallace, Benjamin D Sommers

Importance: Adult dental coverage under Medicaid varies widely across states and delivery systems. Most adult beneficiaries are now enrolled in managed care, yet little is known about how these benefits are structured and implemented within Medicaid managed care organizations (MCOs).

Objective: To examine trends in the generosity, delivery models, and enrollment patterns of adult dental benefits delivered through Medicaid MCOs and assess coverage alignment with Medicaid fee-for-service (FFS) coverage.

Design, setting, and participants: This cross-sectional analysis included adult Medicaid beneficiaries aged 19 years or older who had state Medicaid MCO or FFS coverage across all 50 states and Washington, DC. This analysis used a novel linked national dataset combining multiple Centers for Medicare & Medicaid Services administrative sources from 2016 to 2022. The analysis was conducted from April 8, 2025, to October 8, 2025.

Exposures: State-level Medicaid MCO or FFS program with adult comprehensive dental coverage, emergency-only dental coverage, or no dental coverage.

Main outcomes and measures: The generosity of dental benefits; the degree of alignment in benefit generosity between Medicaid MCO and Medicaid FFS programs; and enrollment of adults in dental MCO or FFS programs by benefit (coverage) type.

Results: The number of states offering comprehensive adult dental benefits through Medicaid MCOs increased from 33 (64.7%) in 2016 to 36 (70.6%) in 2022. Carve-out models, typically using stand-alone prepaid health plans for dental coverage, increased from 4 states (7.8%) in 2016 to 8 states (15.7%) in 2022. In 2016, 51.0% of states had mismatched benefit levels between MCO and FFS programs compared with 35.3% in 2022. The number of MCO enrollees with comprehensive dental coverage increased from 14.2 million (58.7%) in 2016 to 25.3 million (59.8%) in 2022, reflecting substantial managed care penetration.

Conclusions and relevance: This study found that although the generosity and scope of MCO dental benefits expanded over time, alignment with FFS programs remained inconsistent. As new legislation cuts federal funding to states, understanding how dental benefits are designed and delivered is critical to inform future coverage decisions and ensure equitable access.

重要性:医疗补助下的成人牙科覆盖范围在各州和交付系统之间差异很大。大多数成年受益人现在都参加了管理式医疗保健,但很少有人知道这些福利是如何在医疗补助管理式医疗组织(MCOs)中组织和实施的。目的:研究通过医疗补助mco提供的成人牙科福利的慷慨程度、提供模式和登记模式的趋势,并评估医疗补助按服务收费(FFS)覆盖范围的一致性。设计、环境和参与者:本横断面分析包括所有50个州和华盛顿特区19岁或以上的州医疗补助MCO或FFS覆盖的成年医疗补助受益人。该分析使用了一个新的关联国家数据集,结合了2016年至2022年多个医疗保险和医疗补助服务中心的行政来源。分析时间为2025年4月8日至2025年10月8日。暴露:有成人综合牙科保险、仅紧急牙科保险或无牙科保险的州一级医疗补助MCO或FFS计划。主要结果和措施:牙科福利慷慨;医疗补助MCO和医疗补助FFS项目之间的福利慷慨程度的一致性;以及按福利(覆盖)类型登记参加牙科MCO或FFS计划的成人人数。结果:通过医疗补助mco提供综合成人牙科福利的州从2016年的33个(64.7%)增加到2022年的36个(70.6%)。独立模式,通常使用独立的预付费健康计划来支付牙科保险,从2016年的4个州(7.8%)增加到2022年的8个州(15.7%)。2016年,51.0%的州的MCO和FFS计划之间的效益水平不匹配,而2022年这一比例为35.3%。综合牙科覆盖的MCO参保人数从2016年的1420万(58.7%)增加到2022年的2530万(59.8%),反映出管理式医疗的大量渗透。结论和相关性:本研究发现,尽管MCO牙科福利的慷慨程度和范围随着时间的推移而扩大,但与FFS计划的一致性仍然不一致。由于新的立法削减了对各州的联邦资金,了解牙科福利是如何设计和提供的,这对未来的保险决策和确保公平获得至关重要。
{"title":"Dental Coverage Through Medicaid Managed Care vs Fee-for-Service.","authors":"Hawazin W Elani, Ningsheng Zhao, Jacob Wallace, Benjamin D Sommers","doi":"10.1001/jamahealthforum.2025.6958","DOIUrl":"10.1001/jamahealthforum.2025.6958","url":null,"abstract":"<p><strong>Importance: </strong>Adult dental coverage under Medicaid varies widely across states and delivery systems. Most adult beneficiaries are now enrolled in managed care, yet little is known about how these benefits are structured and implemented within Medicaid managed care organizations (MCOs).</p><p><strong>Objective: </strong>To examine trends in the generosity, delivery models, and enrollment patterns of adult dental benefits delivered through Medicaid MCOs and assess coverage alignment with Medicaid fee-for-service (FFS) coverage.</p><p><strong>Design, setting, and participants: </strong>This cross-sectional analysis included adult Medicaid beneficiaries aged 19 years or older who had state Medicaid MCO or FFS coverage across all 50 states and Washington, DC. This analysis used a novel linked national dataset combining multiple Centers for Medicare & Medicaid Services administrative sources from 2016 to 2022. The analysis was conducted from April 8, 2025, to October 8, 2025.</p><p><strong>Exposures: </strong>State-level Medicaid MCO or FFS program with adult comprehensive dental coverage, emergency-only dental coverage, or no dental coverage.</p><p><strong>Main outcomes and measures: </strong>The generosity of dental benefits; the degree of alignment in benefit generosity between Medicaid MCO and Medicaid FFS programs; and enrollment of adults in dental MCO or FFS programs by benefit (coverage) type.</p><p><strong>Results: </strong>The number of states offering comprehensive adult dental benefits through Medicaid MCOs increased from 33 (64.7%) in 2016 to 36 (70.6%) in 2022. Carve-out models, typically using stand-alone prepaid health plans for dental coverage, increased from 4 states (7.8%) in 2016 to 8 states (15.7%) in 2022. In 2016, 51.0% of states had mismatched benefit levels between MCO and FFS programs compared with 35.3% in 2022. The number of MCO enrollees with comprehensive dental coverage increased from 14.2 million (58.7%) in 2016 to 25.3 million (59.8%) in 2022, reflecting substantial managed care penetration.</p><p><strong>Conclusions and relevance: </strong>This study found that although the generosity and scope of MCO dental benefits expanded over time, alignment with FFS programs remained inconsistent. As new legislation cuts federal funding to states, understanding how dental benefits are designed and delivered is critical to inform future coverage decisions and ensure equitable access.</p>","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256958"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12949447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at Retail Pharmacies by State and Payer Type. 按州和付款人类型分零售药店处方的市场集中度。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6546
Dima Mazen Qato, Yugen Chen, Karen Van Nuys
{"title":"Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at Retail Pharmacies by State and Payer Type.","authors":"Dima Mazen Qato, Yugen Chen, Karen Van Nuys","doi":"10.1001/jamahealthforum.2025.6546","DOIUrl":"10.1001/jamahealthforum.2025.6546","url":null,"abstract":"","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256546"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12881978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Physician Emigration and Density After the 2010 WHO Global Code of Practice. 2010年世卫组织全球行为准则实施后医生移民和密度的变化。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6718
Tarun Ramesh, Joia S Mukherjee, Fang Zhang, Anupam B Jena, Hao Yu

Importance: Physician emigration from low- and middle-income countries to high-income countries is a major driver of inequitable distribution of health care and health outcomes across the world. World Health Organization (WHO) signatory countries unanimously signed the voluntary Global Code of Practice on the International Recruitment of Health Personnel (WHO Code) in 2010. The goal was to reduce health care workforce emigration by discouraging active recruitment of physicians from WHO-designated shortage countries and by promoting investment in the physician workforce in those countries. This study adds to the literature by providing evidence about whether the goal has been achieved 10 years after worldwide implementation of the WHO Code.

Objective: To evaluate whether the WHO Code was associated with changes in physician emigration and physician density in WHO-designated shortage countries after 2010.

Design, setting, and participants: A difference-in-differences design was used to examine trends in physician supply before and after 2010. The data (from 2000 through 2021) were collected by the Organization for Economic Co-operation and Development (OECD) and were used to examine physician outflow from 56 WHO-designated shortage countries vs 116 nonshortage countries. The data analysis took place October 2024 to September 2025.

Exposures: Worldwide adoption of the 2010 WHO Code.

Main outcomes and measures: The primary outcome was annual physician migration to OECD countries and the secondary outcome was physician density by country and year (per 1000 population using World Bank data) in the origin countries.

Results: A total of 135 888 physicians emigrated from WHO-designated shortage countries during 2000 to 2021 and 516 030 physicians emigrated from nonshortage countries. Compared with nonshortage countries, there was a decrease in physician outflow by 47.03 physicians (95% CI, -92.29 to -1.76 physicians) per country per year after 2010 in WHO-designated shortage countries and the WHO Code was associated with a reduction of nearly 30% in the average annual outflow of physicians from these countries. However, there was a slight decrease in physician density in the WHO-designated shortage countries after 2010 (-0.22 [95% CI, -0.33 to -0.11] physicians per 1000 population) compared with the nonshortage countries.

Conclusions and relevance: This study found that voluntary implementation of the WHO Code was associated with lower physician outflow from WHO-designated shortage countries without improvement in physician density in those countries.

重要性:医生从低收入和中等收入国家向高收入国家移民是世界各地卫生保健和卫生成果分配不公平的主要驱动因素。世界卫生组织(世卫组织)签署国于2010年一致签署了自愿的《全球卫生人员国际招聘业务守则》(世卫组织守则)。目标是通过阻止从世卫组织指定的短缺国家积极招聘医生和促进对这些国家医生劳动力的投资,减少卫生保健人力的移徙。本研究通过提供证据证明在世界范围内实施世卫组织守则10年后是否实现了这一目标,从而补充了文献。目的:评估世卫组织准则是否与2010年后世卫组织指定短缺国家的医生移民和医生密度变化有关。设计、环境和参与者:采用差异中的差异设计来检查2010年前后医生供应的趋势。这些数据(2000年至2021年)由经济合作与发展组织(经合组织)收集,用于检查56个世卫组织指定的短缺国家与116个非短缺国家的医生外流情况。数据分析时间为2024年10月至2025年9月。暴露:世界范围内采用2010年世卫组织守则。主要结局和措施:主要结局是每年向经合组织国家的医生迁移,次要结局是原籍国按国家和年份划分的医生密度(使用世界银行数据的每1000人)。结果:2000年至2021年期间,共有135 888名医生从世卫组织指定的短缺国家移民,516 030名医生从非短缺国家移民。与非短缺国家相比,2010年以后,在世卫组织指定的短缺国家,每年每个国家的医生外流减少了47.03名医生(95% CI, -92.29至-1.76名医生),世卫组织守则与这些国家每年平均医生外流减少近30%有关。然而,2010年后,与非短缺国家相比,世卫组织指定的短缺国家的医生密度略有下降(每1000人-0.22 [95% CI, -0.33至-0.11]名医生)。结论和相关性:本研究发现,自愿实施《世卫组织守则》与世卫组织指定短缺国家的医生外流减少有关,但这些国家的医生密度没有改善。
{"title":"Changes in Physician Emigration and Density After the 2010 WHO Global Code of Practice.","authors":"Tarun Ramesh, Joia S Mukherjee, Fang Zhang, Anupam B Jena, Hao Yu","doi":"10.1001/jamahealthforum.2025.6718","DOIUrl":"10.1001/jamahealthforum.2025.6718","url":null,"abstract":"<p><strong>Importance: </strong>Physician emigration from low- and middle-income countries to high-income countries is a major driver of inequitable distribution of health care and health outcomes across the world. World Health Organization (WHO) signatory countries unanimously signed the voluntary Global Code of Practice on the International Recruitment of Health Personnel (WHO Code) in 2010. The goal was to reduce health care workforce emigration by discouraging active recruitment of physicians from WHO-designated shortage countries and by promoting investment in the physician workforce in those countries. This study adds to the literature by providing evidence about whether the goal has been achieved 10 years after worldwide implementation of the WHO Code.</p><p><strong>Objective: </strong>To evaluate whether the WHO Code was associated with changes in physician emigration and physician density in WHO-designated shortage countries after 2010.</p><p><strong>Design, setting, and participants: </strong>A difference-in-differences design was used to examine trends in physician supply before and after 2010. The data (from 2000 through 2021) were collected by the Organization for Economic Co-operation and Development (OECD) and were used to examine physician outflow from 56 WHO-designated shortage countries vs 116 nonshortage countries. The data analysis took place October 2024 to September 2025.</p><p><strong>Exposures: </strong>Worldwide adoption of the 2010 WHO Code.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was annual physician migration to OECD countries and the secondary outcome was physician density by country and year (per 1000 population using World Bank data) in the origin countries.</p><p><strong>Results: </strong>A total of 135 888 physicians emigrated from WHO-designated shortage countries during 2000 to 2021 and 516 030 physicians emigrated from nonshortage countries. Compared with nonshortage countries, there was a decrease in physician outflow by 47.03 physicians (95% CI, -92.29 to -1.76 physicians) per country per year after 2010 in WHO-designated shortage countries and the WHO Code was associated with a reduction of nearly 30% in the average annual outflow of physicians from these countries. However, there was a slight decrease in physician density in the WHO-designated shortage countries after 2010 (-0.22 [95% CI, -0.33 to -0.11] physicians per 1000 population) compared with the nonshortage countries.</p><p><strong>Conclusions and relevance: </strong>This study found that voluntary implementation of the WHO Code was associated with lower physician outflow from WHO-designated shortage countries without improvement in physician density in those countries.</p>","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256718"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12881981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Role for Market Forces in US Health Care-Principles and Guardrails. 市场力量在美国医疗保健中的作用——原则和防护措施。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6478
Sandro Galea
{"title":"A Role for Market Forces in US Health Care-Principles and Guardrails.","authors":"Sandro Galea","doi":"10.1001/jamahealthforum.2025.6478","DOIUrl":"https://doi.org/10.1001/jamahealthforum.2025.6478","url":null,"abstract":"","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256478"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders. 青少年大麻使用与精神病、双相情感障碍、抑郁症和焦虑症的风险。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6839
Kelly C Young-Wolff, Catherine A Cortez, Stacey E Alexeeff, Lynn D Silver, Rosalie Liccardo Pacula, Natalie E Slama, Alisa A Padon, Derek D Satre, Cynthia I Campbell, Maria T Koshy, Monique B Does, Stacy A Sterling
<p><strong>Importance: </strong>As cannabis becomes more accessible and socially accepted, concerns have grown about its potential implications for adolescent mental health. While prior research has linked adolescent cannabis use to psychiatric symptoms, few large, population-based, longitudinal studies have examined associations with clinically diagnosed psychiatric disorders.</p><p><strong>Objective: </strong>To evaluate whether adolescent cannabis use is associated with an increased risk of incident psychotic, bipolar, depressive, and anxiety disorders during adolescence and young adulthood.</p><p><strong>Design, setting, and participants: </strong>This cohort study included adolescents aged 13 to 17 years who were screened for past-year cannabis use at Kaiser Permanente Northern California from 2016 to 2023. Adolescents were followed up through age 25 years or until December 31, 2023. Data were analyzed from February 21, 2024, to August 27, 2025.</p><p><strong>Exposure: </strong>Time-varying self-reported past-year cannabis use based on universal, confidential screening during standard pediatric care.</p><p><strong>Main outcomes and measures: </strong>Incident clinician-diagnosed psychotic, bipolar, depressive, and anxiety disorders, which were identified through electronic health records using International Classification of Disease codes. Cox proportional hazards regression models were used to measure the strength of associations between adolescent cannabis use and incident psychiatric diagnoses, with adjustments for sex, race and ethnicity, neighborhood deprivation index, insurance type, and time-varying alcohol and other substance use.</p><p><strong>Results: </strong>Of 463 396 adolescents (234 114 males [50.5%]; mean [SD] age, 14.5 [1.3] years) included in the sample, 136 708 were Hispanic individuals (29.5%), 93 737 were non-Hispanic Asian individuals (20.2%), 35 346 were non-Hispanic Black individuals (7.6%), 153 102 were non-Hispanic White individuals (33.0%), and 18 795 individuals were multiracial or of other races or ethnicities (4.1%). At baseline, 26 345 adolescents (5.7%) self-reported past-year cannabis use. Past-year cannabis use was associated with an increased risk of incident psychotic (adjusted hazard ratio [AHR], 2.19; 95% CI, 1.97-2.42), bipolar (AHR, 2.01; 95% CI, 1.82-2.22), depressive (AHR, 1.34; 95% CI, 1.30-1.39), and anxiety disorders (AHR, 1.24; 95% CI, 1.21-1.28). The strength of the associations between cannabis use and incident depressive and anxiety disorders decreased as adolescents aged. This pattern was similar but slightly attenuated after additional adjustment for past psychiatric conditions (psychotic disorder: AHR, 1.92; 95% CI, 1.73-2.13; bipolar disorder: AHR, 1.73; 95% CI, 1.57-1.90; depressive disorder: AHR, 1.33; 95% CI, 1.29-1.38; anxiety disorder: AHR, 1.19; 95% CI, 1.16-1.23).</p><p><strong>Conclusions and relevance: </strong>This cohort study found that adolescent cannabis use was associated wi
重要性:随着大麻越来越容易获得和被社会接受,人们越来越关注其对青少年心理健康的潜在影响。虽然先前的研究将青少年使用大麻与精神症状联系起来,但很少有大型、基于人群的纵向研究检查了与临床诊断的精神疾病的关系。目的:评估青少年大麻使用是否与青春期和青年期精神病、双相情感障碍、抑郁症和焦虑症发生风险增加有关。设计、环境和参与者:该队列研究包括13至17岁的青少年,他们在2016年至2023年期间在北加州凯撒医疗机构接受了过去一年的大麻使用筛查。这些青少年被随访至25岁或2023年12月31日。数据分析时间为2024年2月21日至2025年8月27日。暴露:时间变化的自我报告过去一年的大麻使用基于普遍的,保密筛选在标准儿科护理。主要结果和测量:临床诊断的精神病、双相情感障碍、抑郁症和焦虑症,通过使用国际疾病分类代码的电子健康记录进行识别。使用Cox比例风险回归模型来测量青少年大麻使用与事件精神诊断之间的关联强度,并对性别、种族和民族、邻里剥夺指数、保险类型以及随时间变化的酒精和其他物质使用进行调整。结果:在463 396名青少年中(男性234 114名[50.5%],平均[SD]年龄14.5[1.3]岁),西班牙裔136 708人(29.5%),非西班牙裔亚裔93 737人(20.2%),非西班牙裔黑人35 346人(7.6%),非西班牙裔白人153 102人(33.0%),多种族或其他种族或民族18 795人(4.1%)。在基线时,26345名青少年(5.7%)自我报告过去一年使用大麻。过去一年的大麻使用与精神病(校正风险比[AHR], 2.19; 95% CI, 1.97-2.42)、双相情感障碍(AHR, 2.01; 95% CI, 1.82-2.22)、抑郁症(AHR, 1.34; 95% CI, 1.30-1.39)和焦虑症(AHR, 1.24; 95% CI, 1.21-1.28)的发生风险增加相关。随着青少年年龄的增长,大麻使用与抑郁症和焦虑症之间的联系减弱。这种模式相似,但在对过去的精神状况进行额外调整后略有减弱(精神障碍:AHR, 1.92; 95% CI, 1.73-2.13;双相情感障碍:AHR, 1.73; 95% CI, 1.57-1.90;抑郁症:AHR, 1.33; 95% CI, 1.29-1.38;焦虑症:AHR, 1.19; 95% CI, 1.16-1.23)。结论和相关性:该队列研究发现,青少年大麻使用与精神疾病风险增加有关,特别是精神病和双相情感障碍。这些结果可以为父母、青少年和临床医生制定临床和教育干预措施,以及在扩大大麻合法化的背景下预防或延迟青少年使用大麻的保护性政策提供信息。
{"title":"Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders.","authors":"Kelly C Young-Wolff, Catherine A Cortez, Stacey E Alexeeff, Lynn D Silver, Rosalie Liccardo Pacula, Natalie E Slama, Alisa A Padon, Derek D Satre, Cynthia I Campbell, Maria T Koshy, Monique B Does, Stacy A Sterling","doi":"10.1001/jamahealthforum.2025.6839","DOIUrl":"10.1001/jamahealthforum.2025.6839","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;As cannabis becomes more accessible and socially accepted, concerns have grown about its potential implications for adolescent mental health. While prior research has linked adolescent cannabis use to psychiatric symptoms, few large, population-based, longitudinal studies have examined associations with clinically diagnosed psychiatric disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate whether adolescent cannabis use is associated with an increased risk of incident psychotic, bipolar, depressive, and anxiety disorders during adolescence and young adulthood.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This cohort study included adolescents aged 13 to 17 years who were screened for past-year cannabis use at Kaiser Permanente Northern California from 2016 to 2023. Adolescents were followed up through age 25 years or until December 31, 2023. Data were analyzed from February 21, 2024, to August 27, 2025.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposure: &lt;/strong&gt;Time-varying self-reported past-year cannabis use based on universal, confidential screening during standard pediatric care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;Incident clinician-diagnosed psychotic, bipolar, depressive, and anxiety disorders, which were identified through electronic health records using International Classification of Disease codes. Cox proportional hazards regression models were used to measure the strength of associations between adolescent cannabis use and incident psychiatric diagnoses, with adjustments for sex, race and ethnicity, neighborhood deprivation index, insurance type, and time-varying alcohol and other substance use.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of 463 396 adolescents (234 114 males [50.5%]; mean [SD] age, 14.5 [1.3] years) included in the sample, 136 708 were Hispanic individuals (29.5%), 93 737 were non-Hispanic Asian individuals (20.2%), 35 346 were non-Hispanic Black individuals (7.6%), 153 102 were non-Hispanic White individuals (33.0%), and 18 795 individuals were multiracial or of other races or ethnicities (4.1%). At baseline, 26 345 adolescents (5.7%) self-reported past-year cannabis use. Past-year cannabis use was associated with an increased risk of incident psychotic (adjusted hazard ratio [AHR], 2.19; 95% CI, 1.97-2.42), bipolar (AHR, 2.01; 95% CI, 1.82-2.22), depressive (AHR, 1.34; 95% CI, 1.30-1.39), and anxiety disorders (AHR, 1.24; 95% CI, 1.21-1.28). The strength of the associations between cannabis use and incident depressive and anxiety disorders decreased as adolescents aged. This pattern was similar but slightly attenuated after additional adjustment for past psychiatric conditions (psychotic disorder: AHR, 1.92; 95% CI, 1.73-2.13; bipolar disorder: AHR, 1.73; 95% CI, 1.57-1.90; depressive disorder: AHR, 1.33; 95% CI, 1.29-1.38; anxiety disorder: AHR, 1.19; 95% CI, 1.16-1.23).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;This cohort study found that adolescent cannabis use was associated wi","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256839"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12924094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolescent and Young Adult Requests for Medication Abortion Through Online Telemedicine. 青少年和年轻成人通过在线远程医疗请求药物流产。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6808
Dana M Johnson, Jennifer E Starling, Rebecca Gomperts
{"title":"Adolescent and Young Adult Requests for Medication Abortion Through Online Telemedicine.","authors":"Dana M Johnson, Jennifer E Starling, Rebecca Gomperts","doi":"10.1001/jamahealthforum.2025.6808","DOIUrl":"10.1001/jamahealthforum.2025.6808","url":null,"abstract":"","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256808"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12905652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JAMA Health Forum. JAMA健康论坛。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6020
{"title":"JAMA Health Forum.","authors":"","doi":"10.1001/jamahealthforum.2025.6020","DOIUrl":"https://doi.org/10.1001/jamahealthforum.2025.6020","url":null,"abstract":"","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256020"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Online Sports Betting Is a Public Policy Issue and a Public Health Issue. 在线体育博彩是一个公共政策问题,也是一个公共卫生问题。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6926
Matthew D Eisenberg, Benjamin Westermeyer, Mark K Meiselbach
{"title":"Online Sports Betting Is a Public Policy Issue and a Public Health Issue.","authors":"Matthew D Eisenberg, Benjamin Westermeyer, Mark K Meiselbach","doi":"10.1001/jamahealthforum.2025.6926","DOIUrl":"https://doi.org/10.1001/jamahealthforum.2025.6926","url":null,"abstract":"","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256926"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Systems Approaches for Advancing Implementation and Policy for Food is Medicine. 促进实施的卫生系统方法和粮食政策。
IF 11.3 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1001/jamahealthforum.2025.6866
Priyansh P Shah, Monica Aggarwal, Karen E Aspry, Emily A Callahan, Robert Ostfeld, Dariush Mozaffarian, Lily N Dastmalchi, Robert T Faillace, Andrew M Freeman

Importance: Poor nutrition remains the leading modifiable risk factor for cardiovascular disease and its major risk actors, contributing to substantial morbidity, early disability, mortality, economic burdens, and health disparities in the US. Food is Medicine (FIM) is a growing movement that integrates food-based nutrition interventions into health care delivery to prevent, manage, and treat diet-related chronic diseases. Early research has indicated that FIM interventions including produce prescriptions, medically tailored groceries, and medically tailored meal are promising as cost-effective approaches to improve cardiovascular disease and associated health outcomes. Delivered in coordination with health care systems, FIM interventions are increasingly supported by federal and state legislative efforts, the latter via Medicaid Section 1115 waivers and in lieu of service pathways, as well as some private payers.

Observations: Although coverage and policy pathways for FIM remain fragmented, cardiovascular specialists and other clinicians have an opportunity to play pivotal roles in operationalizing FIM in health systems through systematic screening for nutrition insecurity, risk stratification, closed-loop referral workflows, quality improvement through outcome measurement and monitoring, and patient education, as supported by electronic health record integration and multidisciplinary teams. Implementation science can assist clinicians in optimizing FIM delivery and scalability by standardizing eligibility criteria, intervention dose, duration of benefits, culturally tailored patient education, and clinician awareness. Clinician-initiated research, policy engagement, and health system leadership will also help to advance FIM, especially as a foundational component of value-based care delivery and health equity.

Conclusions and relevance: FIM policies and clinical integration potentially offer an opportunity to address the root causes of cardiometabolic disease, better manage health care costs, and promote health equity. Continued research, policy reform, and clinician engagement are needed to realize the full potential of FIM in 21st century medical practice.

重要性:营养不良仍然是心血管疾病及其主要风险因素的主要可改变风险因素,在美国导致大量发病率、早期残疾、死亡率、经济负担和健康差距。食品即医学(Food is Medicine, FIM)是一项不断发展的运动,旨在将基于食物的营养干预措施整合到卫生保健服务中,以预防、管理和治疗与饮食有关的慢性病。早期研究表明,FIM干预措施,包括生产处方、医学定制食品和医学定制膳食,有望成为改善心血管疾病和相关健康结果的经济有效方法。FIM干预措施与卫生保健系统协调提供,越来越多地得到联邦和州立法努力的支持,后者通过医疗补助第1115节豁免和代替服务途径,以及一些私人支付者。观察结果:尽管FIM的覆盖范围和政策途径仍然不完整,但心血管专家和其他临床医生有机会通过系统筛查营养不安全、风险分层、闭环转诊工作流程、通过结果测量和监测提高质量以及患者教育,在电子健康记录整合和多学科团队的支持下,在卫生系统中实施FIM方面发挥关键作用。实施科学可以帮助临床医生通过标准化的资格标准、干预剂量、获益持续时间、文化定制的患者教育和临床医生意识来优化FIM的交付和可扩展性。临床医生发起的研究、政策参与和卫生系统领导也将有助于推进FIM,特别是作为基于价值的医疗服务和卫生公平的基础组成部分。结论和相关性:FIM政策和临床整合可能为解决心脏代谢疾病的根本原因、更好地管理卫生保健成本和促进卫生公平提供机会。为了在21世纪的医疗实践中充分发挥FIM的潜力,需要持续的研究、政策改革和临床医生的参与。
{"title":"Health Systems Approaches for Advancing Implementation and Policy for Food is Medicine.","authors":"Priyansh P Shah, Monica Aggarwal, Karen E Aspry, Emily A Callahan, Robert Ostfeld, Dariush Mozaffarian, Lily N Dastmalchi, Robert T Faillace, Andrew M Freeman","doi":"10.1001/jamahealthforum.2025.6866","DOIUrl":"https://doi.org/10.1001/jamahealthforum.2025.6866","url":null,"abstract":"<p><strong>Importance: </strong>Poor nutrition remains the leading modifiable risk factor for cardiovascular disease and its major risk actors, contributing to substantial morbidity, early disability, mortality, economic burdens, and health disparities in the US. Food is Medicine (FIM) is a growing movement that integrates food-based nutrition interventions into health care delivery to prevent, manage, and treat diet-related chronic diseases. Early research has indicated that FIM interventions including produce prescriptions, medically tailored groceries, and medically tailored meal are promising as cost-effective approaches to improve cardiovascular disease and associated health outcomes. Delivered in coordination with health care systems, FIM interventions are increasingly supported by federal and state legislative efforts, the latter via Medicaid Section 1115 waivers and in lieu of service pathways, as well as some private payers.</p><p><strong>Observations: </strong>Although coverage and policy pathways for FIM remain fragmented, cardiovascular specialists and other clinicians have an opportunity to play pivotal roles in operationalizing FIM in health systems through systematic screening for nutrition insecurity, risk stratification, closed-loop referral workflows, quality improvement through outcome measurement and monitoring, and patient education, as supported by electronic health record integration and multidisciplinary teams. Implementation science can assist clinicians in optimizing FIM delivery and scalability by standardizing eligibility criteria, intervention dose, duration of benefits, culturally tailored patient education, and clinician awareness. Clinician-initiated research, policy engagement, and health system leadership will also help to advance FIM, especially as a foundational component of value-based care delivery and health equity.</p><p><strong>Conclusions and relevance: </strong>FIM policies and clinical integration potentially offer an opportunity to address the root causes of cardiometabolic disease, better manage health care costs, and promote health equity. Continued research, policy reform, and clinician engagement are needed to realize the full potential of FIM in 21st century medical practice.</p>","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 2","pages":"e256866"},"PeriodicalIF":11.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA Health Forum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1